Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer
Tóm tắt
The Sp/KLF family contains at least twenty identified members which include Sp1‐4 and numerous krüppel‐like factors. Members of the family bind with varying affinities to sequences designated as ‘Sp1 sites’ (e.g., GC‐boxes, CACCC‐boxes, and basic transcription elements). Family members have different transcriptional properties and can modulate each other's activity by a variety of mechanisms. Since cells can express multiple family members, Sp/KLF factors are likely to make up a transcriptional network through which gene expression can be fine‐tuned. ‘Sp1 site’‐dependent transcription can be growth‐regulated, and the activity, expression, and/or post‐translational modification of multiple family members is altered with cell growth. Furthermore, Sp/KLF factors are involved in many growth‐related signal transduction pathways and their overexpression can have positive or negative effects on proliferation. In addition to growth control, Sp/KLF factors have been implicated in apoptosis and angiogenesis; thus, the family is involved in several aspects of tumorigenesis. Consistent with a role in cancer, Sp/KLF factors interact with oncogenes and tumor suppressors, they can be oncogenic themselves, and altered expression of family members has been detected in tumors. Effects of changes in Sp/KLF factors are context‐dependent and can appear contradictory. Since these factors act within a network, this diversity of effects may arise from differences in the expression profile of family members in various cells. Thus, it is likely that the properties of the overall network of Sp/KLF factors play a determining role in regulation of cell growth and tumor progression. © 2001 Wiley‐Liss, Inc.
Từ khóa
Tài liệu tham khảo
Alliston TN, 2000, Expression and localization of serum/glucocorticoid‐induced kinase in the rat ovary: relation to follicular growth and differentiation, Endocrinology, 141, 385, 10.1210/endo.141.1.7257
Black AR, 1996, Transcriptional regulation of growth‐related genes by E2F and Sp1, The Pezcoller Foundation Journal, 3, 4
Borellini F, 1993, Induction of Sp1‐p53 DNA‐binding heterocomplexes during granulocyte/macrophage colony‐stimulating factor‐dependent proliferation in human erythroleukemia cell line TF‐1, J Biol Chem, 268, 7923, 10.1016/S0021-9258(18)53046-5
Chen F, 2000, Ectopic expression of truncated Sp1 transcription factor prolongs the S phase and reduces the growth rate, Anticancer Res, 20, 661
D'Angelo DD, 1996, Novel role for Sp1 in phorbol ester enhancement of human platelet thromboxane receptor gene expression, J Biol Chem, 271, 19696, 10.1074/jbc.271.33.19696
Eid MA, 1998, Expression of early growth response genes in human prostate cancer, Cancer Res, 58, 2461
Foster KW, 1999, Oncogene expression cloning by retroviral transduction of adenovirus E1A‐immortalized rat kidney RK3E cells: transformation of a host with epithelial features by c‐MYC and the zinc finger protein GKLF, Cell Growth Differ, 10, 423
Foster KW, 2000, Increase of GKLF messenger RNA and protein expression during progression of breast cancer, Cancer Res, 60, 6488
Ishibashi H, 2000, Sp1 decoy transfected to carcinoma cells suppresses the expression of vascular endothelial growth factor, transforming growth factor beta1, and tissue factor and also cell growth and invasion activities, Cancer Res, 60, 6531
Kavurma MM, 2000, Sp1 phosphorylation regulates apoptosis via extracellular FasL‐Fas engagement, J Biol Chem, 26, 26
Kim SJ, 1989, Activation of the second promoter of the transforming growth factor‐ beta 1 gene by transforming growth factor‐beta 1 and phorbol ester occurs through the same target sequences, J Biol Chem, 264, 19373, 10.1016/S0021-9258(19)47311-0
Kollmar R, 1994, Start site selection at the TATA‐less carbamoyl‐phosphate synthase (glutamine‐hydrolyzing)/aspartate carbamoyltransferase/dihydroorotase promoter, J Biol Chem, 269, 2252, 10.1016/S0021-9258(17)42161-2
Li F, 1999, The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle‐dependent expression, Cancer Res, 59, 3143
Liu C, 1998, Suppression of growth and transformation and induction of apoptosis by EGR‐1, Cancer Gene Ther, 5, 3
Martin KM, 2000, Mouse BTEB3, a new member of the basic transcription element binding protein (BTEB) family, activates expression from GC‐rich minimal promoter regions, Biochem J, 345, 529, 10.1042/bj3450529
Opitz OG, 2000, Interaction between Sp1 and cell cycle regulatory proteins is important in transactivation of a differentiation‐related gene, Cancer Res, 60, 2825
Pena P, 1999, Activator protein‐2 mediates transcriptional activation of the CYP11A1 gene by interaction with Sp1 rather than binding to DNA, Mol Endocrinol, 13, 1402, 10.1210/mend.13.8.0335
Perrem K, 1995, p53 represses SV40 transcription by preventing formation of transcription complexes, Oncogene, 11, 1299
Schilling LJ, 1995, The bidirectionally transcribed dihydrofolate reductase and rep‐3a promoters are growth regulated by distinct mechanisms, Cell Growth Differ, 6, 541
Shie JL, 2000, Role of gut‐enriched Kruppel‐like factor in colonic cell growth and differentiation, Am J Physiol Gastrointest Liver Physiol, G806, 10.1152/ajpgi.2000.279.4.G806
Sif S, 1993, The v‐Rel oncoprotein increases expression from Sp1 site‐containing promoters in chicken embryo fibroblasts, Oncogene, 8, 2501
Webster NJ, 1996, Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer, Cancer Res, 56, 2781
Zhang L, 2000, Wild‐type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression, Cancer Res, 60, 3655